MFIMFI
LGND icon

Mesirow Financial Investment Management - Fixed Income’s Ligand Pharmaceuticals LGND Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-137,842
Closed -$13.3M – 140
2021
Q4 		$13.3M Sell
137,842
-1,795
-1% -$166K 1.46% 7
2021
Q3 		$12.1M Buy
139,637
+110,390
+377% +$8.54M 1.41% 11
2021
Q2 		$2.39M Buy
29,247
+6,829
+30% +$568K 0.27% 92
2021
Q1 		$2.13M Buy
+22,418
New +$2.12M 0.25% 104
2019
Q1 		– Sell
-100,462
Closed -$8.5M – 124
2018
Q4 		$8.5M Buy
100,462
+26,376
+36% +$2.81M 1.14% 50
2018
Q3 		$12.7M Sell
74,086
-49,741
-40% -$7.5M 1.15% 45
2018
Q2 		$16M Sell
123,827
-11,870
-9% -$1.32M 1.47% 14
2018
Q1 		$14M Sell
135,697
-35,643
-21% -$3.52M 1.37% 24
2017
Q4 		$14.6M Sell
171,340
-55,686
-25% -$4.83M 1.03% 68
2017
Q3 		$19.3M Sell
227,026
-50,759
-18% -$4.02M 1.27% 33
2017
Q2 		$21M Sell
277,785
-1,868
-0.7% -$131K 1.41% 23
2017
Q1 		$18.5M Sell
279,653
-5,314
-2% -$350K 1.23% 35
2016
Q4 		$18.1M Sell
284,967
-47,649
-14% -$3.01M 1.11% 50
2016
Q3 		$21.2M Buy
332,616
+51,560
+18% +$3.79M 1.24% 35
2016
Q2 		$20.9M Buy
+281,056
New +$20.9M 1.22% 39

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's LGND Position: Q1 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Ligand Pharmaceuticals (LGND) in Q1 2022, closing a stake of 137,842 shares — an estimated $13.3M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in LGND in Q2 2016 and held it in 15 quarters. The position peaked at $21.2M in Q3 2016. 208 funds tracked by Wall St. Rank hold LGND as of Q1 2022.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Ligand Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 137,842 Ligand Pharmaceuticals shares in Q1 2022, an estimated $13.3M.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Ligand Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Ligand Pharmaceuticals position peaked at $21.2M in Q3 2016.
  • 208 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q1 2022, filed 9 May 2022.